Register today—https://www.thefutureoftravelmobility.com/
These conversations will identify the factors essential to spur travel’s growth and innovation and discuss the policies required to usher in the future of travel.
Presented by U.S. Travel in partnership with CQ & Roll Call
Register today to join critical conversations on the Future of Travel—https://www.thefutureoftravelmobility.com/
Discuss fundamental questions:
🚆 How to meet strong travel demand and a travel sustainability imperative?
✈️ How to deliver efficient travel and robust travel security?
🚗 What new modes and capabilities will define how we travel in the future?
Presented by U.S. Travel and in partnership with CQ & Roll Call
US Travel presents the third annual Future of Travel Mobility in partnership with CQ & Roll Call.
Join public policy leaders, industry experts, and business leaders to learn more about what it takes to spur innovation and growth in the future of travel—https://www.thefutureoftravelmobility.com/
Registration is now open! Join us at U.S. Travel's third annual Future of Travel Mobility.
Powerhouse speakers, game-changing conversations—join us to explore these themes and more:
▶️Balancing the sustainability imperative while delivering against growing demand
▶️Driving the future of seamless travel security—from curbside to cruising altitude
▶️Defining the modes and capabilities shaping the next generation of travel and connectivity
View confirmed speakers and register here— https://www.thefutureoftravelmobility.com/
Save the Date! The U.S. Travel Association is returning with the Future of Travel Mobility Wednesday, Nov 15th, 2023 in Washington, DC.
Learn more about this year's program & see last year's itinerary— https://www.thefutureoftravelmobility.com/
In partnership with CQ Roll Call
Melted Voting Machines and Missing Merit Raises: The State of Midterm Elections Infrastructure
Election officials from all over the country are struggling to cover a range of budget needs in light of rising costs and new challenges. Between fixed and ongoing funding needs for their security, staffing, equipment, facilities, and more, local election officials scramble yearly to provide voters with the 21st-century voting experience they expect and deserve. The extent of the need is greater than any one locality or state can fully shoulder.
The Global Race to Supply Our Future
Join representatives from the Biden-Harris administration, members of Congress, analysts, industry experts, representatives from the auto and manufacturing industries, supply chain experts, and others, for an event to discuss the skyrocketing need for minerals, and what needs to be done here in the U.S. to ensure that those minerals are sourced here at home, creating secure, domestic supply chains and weaning the U.S. off reliance on geopolitical rivals like China and Russia.
Investing in Innovation: A Blueprint for Enduring American Semiconductor Leadership
From autos to washing machines to medical devices, the products we depend on are built on semiconductors. The global chip shortage has exposed vulnerabilities in the semiconductor supply chain and highlighted the urgent need for U.S. government investments and incentives for domestic chip research, design, and manufacturing.
Other countries are heavily investing in their own chip ecosystems to better prepare for future supply challenges and boost their ability to lead in the advanced tech of tomorrow. The U.S. government is considering bold innovation and competitiveness legislation that would level the global playing field and ensure more of the coming boom in semiconductor production and innovation occurs on U.S. shores.
Join CQ Roll Call and the Semiconductor Industry Association (SIA) to discuss:
- Steps leaders in Washington are considering—including enactment in competitiveness legislation of CHIPS Act funding and a FABS Act investment tax credit for semiconductor manufacturing and design—to strengthen U.S. semiconductor leadership and help avert future chip shortages
- What reinforcing semiconductor research, design, and manufacturing in the U.S. would mean for America's economic resilience, national security, and global competitiveness
Superbugs: Policy Solutions to Tackle an Emerging Health Threat
According to the Centers for Disease Control and Prevention’s (CDC) Antibiotic Resistance Threats in the United States report, more than 2.8 million antibiotic-resistant infections occur in the U.S. each year, and at least 35,000 people die as a result of these “superbugs.”
A robust pipeline of novel antimicrobial medicines is necessary for treatments to keep pace with evolving pathogens. With support from Congress, legislation can incentivize researchers to develop new antimicrobial treatments for infections for which there is an unmet medical need, anticipated clinical need, or drug resistance.
Join CQ Roll Call and Pfizer to discuss:
Patient disease and antimicrobial resistance research
The PASTEUR Act
Opportunities to reduce market failures in producing critical antimicrobials
Modernizing Congress: Moving the House Forward
The House Select Committee on the Modernization of Congress was created in the 116th Congress in the pursuit to make a more efficient and effective Congress for the American people. With the committee in its final year, more than 140 bipartisan recommendations have been offered towards this endeavor.
Since its creation, the Committee has overseen 91 fully or partially implemented recommendations with continuing research and development into avenues to pursue the remaining recommendations, including work to secure continuity in staff operations, digitize legislative processes, improve constituent communication, and more.
Join CQ Roll Call and The House Select Committee on the Modernization of Congress to discuss:
- How committee leadership is ensuring the implementation recommendations
- Current recommendations in progress
- Staffing and resource allotment
Protecting America’s Medicine Cabinet
Continued bicameral and bipartisan collaboration around medical shortages signals the importance of enhancing domestic manufacturing and providing diversity in the supply chain to ensure that essential medicines are available for all Americans without disruption.
Essential medicines are the priority medications that are critical to have available at all times to sustain the health of the American population. Leveraging state-of-the-art green chemistry, continuous flow technology, and other advanced manufacturing processes can improve the development and manufacturing of APIs and finished pharmaceutical products critical to U.S. healthcare while also reducing the nation’s reliance on imports from foreign nations.